Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2026-02-26 @ 1:00 AM
Study NCT ID:
NCT05377034
Status:
RECRUITING
Last Update Posted:
2025-10-06
First Post:
2022-05-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients
Sponsor:
National Cancer Centre, Singapore
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-26
Start Date Type:
ACTUAL
Primary Completion Date:
2026-07-25
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-05-11
First Submit QC Date:
None
Study First Post Date:
2022-05-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-30
Last Update Post Date:
2025-10-06
Last Update Post Date Type:
ESTIMATED